doi:10.1016/j.ctim.2008.11.003
Copyright © 2008 Elsevier Ltd All rights reserved.
Summary
Objectives
To investigate the anti-fatigue effects of Myelophil, an extract of a mix of Astragali Radix and Salviae Radix, which has been used to treat patients with chronic fatigue.
Subjects and design
A randomised, double-blind, controlled clinical trial was performed with 36 adults who complained of chronic fatigue. The subjects were divided among a control group and low- and high-dose groups (3 or 6 g of oral Myelophil per day, respectively) and were monitored for 4 weeks. Fatigue severity was subjectively characterised, and the expression of 42 cytokines was evaluated using an antibody array.
Results
Myelophil administration (3 g per day) significantly decreased the fatigue severity score compared with the control (p < 0.05). No changes were noted in cytokine expression.
Conclusions
Myelophil appears to have a pharmacological effect against fatigue, suggesting the clinical relevance of the traditional medicinal plants, Astragalus membranaceus and Salvia miltiorrhiza.
Keywords: Chronic fatigue; Astragalus membranaceus; Salvia miltiorrhiza; Herbal medicine
Article Outline
- Introduction
- Subjects and methods
- Subjects
- Composition of Myelophil and the placebo
- Study protocol
- Assessment based on the Chalder fatigue severity scale and a visual analogue scale
- Cytokine antibody array
- Statistical analysis
- Results
- Change in fatigue severity as determined by NRS
- Change in fatigue severity as determined by VAS
- Serum cytokine profiles
- Discussion
- Acknowledgements
- References
prptiredness prpcfs prpfatigue


